Human umbilical cord blood-derived mesenchymal stem cell transplantation for the treatment of spinal cord injury

Experimental and Therapeutic Medicine

Volumn 7, Issue 5, 2014, Pages 1233-1236

  Cui, Bingzhou ^a   Li, En ^a   Yang, Bo ^b   Wang, Bo ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Human umbilical cord blood; Mesenchymal stem cells; Rat; Spinal cord injury; Transplantation

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC ENOLASE;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL TRANSFER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PROTEIN EXPRESSION; RAT; SCORING SYSTEM; SPINAL CORD FUNCTION; SPINAL CORD INJURY; SPINE PLATE; UMBILICAL CORD BLOOD;

EID: 84896861662     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1608     Document Type: Article

References (38)

1. Akiyama Y, Honmou O, Kato T, Uede T, Hashi K and KocsisJD: Transplantation of clonal neural precursor cells derived from adult human brain establishes functional peripheral myelin in the rat spinal cord. Exp Neurol167: 27-39, 2001.
2. Blesch A, Lu P and Tuszynski MH: Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair. Brain Res Bull57: 833-838, 2002.
3. Einstein O and Ben-Hur T: The changing face of neural stem cell therapy in neurological diseases. Arch Neurol65: 452-456, 2008.
4. Girard C, Bemelmans AP, Dufour N, etal: Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord. JNeurosci25: 7924-7933, 2005.
5. Goldman S: Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol23: 862-871, 2005.
6. Kuh SU, Cho YE, Yoon DH, Kim KN and Ha Y: Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat. Acta Neurochir (Wien) 147: 985-992, 2005.
7. Kwon BK, Fisher CG, Dvorak MF and TetzlaffW: Strategies to promote neural repair and regeneration after spinal cord injury. Spine (Phila Pa 1976) 30 (17Suppl): S3-S13, 2005.
8. López-Vales R, Forés J, Verdú E and Navarro X: Acute and delayed transplantation of olfactory ensheathing cells promote partial recovery after complete transaction of the spinal cord. Neurobiol Dis21: 57-68, 2006.
9. Nakamura M, Toyama Y and Okano H: Transplantation of neural stem cells for spinal cord injury. Rinsho Shinkeigaku45: 874-876, 2005 (In Japanese).
10. Rizek PN and Kawaja MD: Cultures of rat olfactory ensheathing cells are contaminated with Schwann cells. Neuroreport17: 459-462, 2006.
11. Deumens R, Koopmans GC, Lemmens M, etal: Neurite outgrowth promoting effects of enriched and mixed OEC/ONF cultures. Neurosci Lett397: 20-24, 2006.
12. +human umbilical cord blood cells after spinal cord hemisection injury improves functional recovery in adult rats. Cell Transplant13: 113-122, 2004.
13. Bregman BS, Kunkel-Bagden E, Schnell L, Dai HN, GaoD and SchwabME: Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature378: 498-501, 1995.
14. Bregman BS, McAtee M, Dai HN and Kuhn PL: Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat. Exp Neurol148: 475-494, 1997.
15. Popovich PG, Guan Z, Wei P, Huitinga I, van RooijenN and StokesBT: Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after exprimental spinal cord injury. Exp Neurol158: 351-365, 1999.
16. Kishk NA, Gabr H, Hamdy S, etal: Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury. Neurorehabil Neural Repair24: 702-708, 2010.
17. Pal R, Venkataramana NK, Bansal A, etal: Exvivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy11: 897-911, 2009.
18. Saito F, Nakatani T, Iwase M, etal: Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report. J Trauma64: 53-59, 2008.
19. Chiu B, Wan JZ, Abley D and Akabutu J: Induction of vascular endothelial phenotype and cellular proliferation from human cord blood stem cells cultured in simulated microgravity. Acta Astronaut56: 918-922, 2005.
20. Hong SH, Gang EJ, Jeong JA, etal: Invitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells. Biochem Biophys Res Commun330: 1153-1161, 2005.
21. Jurga M, Markiewicz I, Sarnowska A, etal: Neurogenic potential of human umbilical cord blood: neural-like stem cells depend on previous long-term culture conditions. J Neurosci Res83: 627-637, 2006.
22. Walczak P, Chen N, Eve D, etal: Long term cultured human umbilical cord neural-like cells transplanted into the striatum of NOD SCID mice. Brain Res Bull74: 155-163, 2007.
23. El-Badri NS, Hakki A, Saporta S, etal: Cord blood mesenchymal stem cells: Potential use in neurological disorders. Stem Cells Dev15: 497-506, 2006.
24. Ankeny DP, McTigue DM and Jakeman LB: Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp Neurol190: 17-31, 2004.
25. Mansilla E, Marin GH, Sturla F, etal: Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries. Transplant Proc37: 292-294, 2005.
26. Schultz SS: Adult stem cell application in spinal cord injury. Curr Drug Targets6: 63-73, 2005.
27. Harris DT: Non-haematological uses of cord blood stem cells. Br J Haematol147: 177-184, 2009.
28. Kim SU and de Vellis J: Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res87: 2183-2200, 2009.
29. Basso DM, Beattie MS and Bresnahan JC: A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12: 1-21, 1995.
30. Tomita S, Mickle DA, Weisel RD, et al: Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 123: 1132-1140, 2002.
31. Wang TT, Tio M, Lee W, Beerheide W and Udolph G: Neural differentiation of mesenchymal-like stem cells from cord blood is mediated by PKA. Biochem Biophys Res Commun 357: 1021-1027, 2007.
32. Pal R, Gopinath C, Rao NM, etal: Functional recovery after transplantation of bone marrow-derived human mesenchymal stromal cells in a rat model of spinal cord injury. Cytotherapy12: 792-806, 2010.
33. Bossolasco P, Cova L, Calzarossa C, etal: Neuro-glial differentiation of human bone marrow stem cells invitro. Exp Neurol193: 312-325, 2005.
34. Bjugstad KB, Redmond DE Jr, Teng YD, etal: Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: a return to control measures. Cell Transplant14: 183-192, 2005.
35. Garbuzova-Davis S, Willing AE, Saporta S, etal: Novel cell therapy approaches for brain repair. Prog Brain Res157: 207-222, 2006.
36. Leu S, Lin YC, Yuen CM, etal: Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J Transl Med8: 63, 2010.
37. Djouad F, Delorme B, Maurice M, etal: Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes. Arthritis Res Ther9: R33, 2007.
38. Crigler L, Robey RC, Asawachaicharn A, Gaupp D and PhinneyDG: Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol198: 54-64, 2006.